Clyde G. Culbertson Oral History Interview, December 3, 1976

Simple item page
dc.contributor.authorBrandt, Rick
dc.contributor.authorSumpter, Wally
dc.date.accessioned2018-03-23T19:54:33Z
dc.date.accessioned2022-11-01T18:33:28Z
dc.date.available2018-03-23T19:54:33Z
dc.date.available2022-11-01T18:33:28Z
dc.date.issued2018-03-23
dc.description.abstractClyde G. Culbertson was a medical educator and researcher who developed a process that enabled the Salk polio vaccine to be mass-produced. He helped oversee the development of vaccines and drugs in his 25 years at Eli Lilly & Company in Indianapolis, where he became the director of biological research. Besides his contribution to the Salk vaccine, Dr. Culbertson helped develop a safer rabies vaccine and the antibiotic erythromycin. He also discovered that nonparasitic amoeba can fatally infect the brains of humans. In honor of his accomplishments, one species, Acanthamoeba culbertsoni, was named for him.en_US
dc.identifier.urihttp://hdl.handle.net/2450/12027
dc.titleClyde G. Culbertson Oral History Interview, December 3, 1976en_US
Files
Collections
Oral Histories